Poster and Platform Presentations

Long-term deep brain stimulation for essential tremor: 12- year clinicopathologic follow up and literature review.

DiLorenzo DJ, Jankovic J, Simpson RK, Takei H, Powell SZ

Double-blind, randomized, placebo-controlled, cross-over trial of pregabalin in essential tremor.

Ferrara FM, Kenney C, Davidson AL, Shinawi L, Kissel AM, Jankovic J

Impact of STN-DBS on health-related quality of life in patients with Parkinson's disease.

Ferrara JM, Diamond A, Davidson A , Almaguer M, Jankovic J

Tourette syndrome in adults.

Gelineau-Kattner RN, Jankovic J, Davidson AL

Efficacy and safety of NT 201 (botulinum neurotoxin type A free from complexing proteins) in treatment-naive cervical dystonia patients.

Grafe S, Comella C, Jankovic J, Truong D, Hanschmann A

Efficacy and safety of NT 201, botulinum neurotoxin type A free from complexing proteins) in pre-treated cervical dystonia patients.

Grafe S, Comella C, Jankovic J, Truong D, Hanschmann A

A randomized, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome.

Jankovic J, Jimenez-Shahed J, Brown LW

Pilocarpine-induced myotic response is greater in PD than in MSA patients.

Lanzafame S, Mostile G, Contrafatto D, Raciti L, Sorbello V, Luca A, Nicoletti A, Zappia M

Transcription factor PITX3 in Parkinson's disease.

Le W, Nguyen D, Lin W, Rawal P, Ding Y, Xie W, Deng H, Jankovic J

Gait analysis is more sensitive than finger tapping or UPDRS motor scores in assessment of the motor response to levodopa in Parkinson's disease.

Moore ST, Shinawi L, Ondo WG

Correlation between Kinesia system assessments and clinical TETRAS scores in patients with essential tremor.

Mostile G, Giuffrida JP, A dam OR, Davidson A, Jankovic J

Intravenous iron dextran for severe refractory restless legs syndrome.

Ondo WG

Task specific writing tremor: Series and outcomes.

Ondo WG, Satija P, Ummat M

17-AAG protects against rotenone-induced apoptosis in SHSY5Y cells via HSP70 induction.

Pan T, Xie W, Jankovic J, Le W

Resveratrol, a polyphenol found in red wine, protects against rotenone-induced apoptosis through autophagy induction.

Pan T, Xie W, Le W, Jankovic J

The course of depressive symptoms in early Parkinson's disease.

Ravina B, Elm J, Camicioli R, Como P, Marsh L, Jankovic J, Weintraub D

Mood differences between women diagnosed with psychogenic movement disorders and psychogenic seizures.

Strutt AM, Ferrara J, Hill S, York MK, Uber-Zak L, Fogel T, Jankovic J

Neuroprotection trials in Parkinson's disease.

Yaltho TC, Hart RG, Pearce LA, Ravina BM, Marler JR

The written and oral administration of the Symbol Digit Modality Test in Huntington disease.

Adam O, Halton S, Mostile G, Jankovic J

The non motor staging of Parkinson's disease: Results from an international study.

Chaudhuri KR, Martinez-Martin P, Sherman R, Naidu Y, Odin P, Sethi K, Ondo W, Stocchi F, Schapira A, PD Non Motor Group

Efficacy and safety of NT 201 (neurotoxin free from complexing proteins) in cervical dystonia.

Comella C, Jankovic J, Truong D, Hanschmann A, Grafe S

Levodopa-induced dyskinesias in spinocerebellar ataxia type 2.

Ferrara JM, Adam OR, Ondo WG

Efficacy and safety of NT 201 (botulinum neurotoxin free from complexing proteins) in blepharospasm.

Jankovic J, Comella C, Hanschmann A, Grafe S

Rapamycin protects against rotenone-induced apoptosis through autophagy induction in SH-SY5Y cells.

Pan T, Xie W, Rawal P, Jankovic J, Le W

A controlled study of the long-term cognitive outcome of bilateral subthalamic nucleus deep brain stimulation.

Williams A, Arzola GM, Strutt AM, Simpson R, Jankovic J, York MK

Voxel-based diffusion tensor imaging and diffusion tensor tractography for the evaluation of cognitive functioning in Parkinson's disease.

York M, Karmonik C, Wilde E, Kakkar E, Yallampalli R, Strutt A, Jankovic J, Grossman R

Short-term and long-term improvement by pramipexole in restless leg syndrome animal model.

Lou FF, Zhu W, Xie W, Ondo W, Le W

Thalamic endogenous opioids are decreased in restless legs syndrome: A post-mortem study.

Walters AS, Ondo W, Zhu W, Le WD

Progressive DA neuron degeneration induced by targeting administration of proteasome inhibitor in SN.

Xie W, Zhu W, Pan T, Jankovic J, Le W

Unusual motor-phonic tic mimicking essential palatal myoclonus (EPM).

Adam OR, Jankovic J

Correlation between clinical rating of parkinsonian and essential tremor and quantitative assessments.

Aguilar LG, Giuffrida JP, Heldman DD, Jankovic J

Exploring the relationship between drug-induced parkinsonism and tardive dyskinesias.

Aguilar Tabora LG, Ondo WG

The essential tremor rating assessment scale (TETRAS).

Elble R, Comella C, Fahn S, Hallett M, Jankovic J, Juncos J, Louis E, Lyons K, Ondo WG, Pahwa R, Sethi K, Stern M, Tanner C, Tarsy D, Tintner R, Watts R, Tremor Research Group

Factors predicting adverse effects to subcutaneous apomorphine.

Ferrara J, Ondo WG

Spinocerebellar Ataxia 8: Variable phenotype and unique pathogenesis.

Gupta A, Jankovic J

Rotigotine 24h transdermal patch is effective in the treatment of idiopathic RLS: Results of a 6-month, multicenter, double-blind, placebo-controlled US trial.

Hening WA, Allen R, Becker PM, Bogan RK, Fry JM, Keffel J, Kudrow DB, Lesh KW, Ondo WG, Schollmayer E, Vrooman P, Walters A, Winkelman JW

Evaluation of a Parkinson's disease screening questionnaire for use in a community-based setting.

Hunter CB, Aguilar LG, Nashatizadeh MM, Lay LF, Jankovic J

The role of dopaminergic medication doses in impulse control disorders (ICD) in Parkinson's disease (PD).

Jimenez-Shahed J, Baker K, Davidson A, Jankovic J

Expanded study of NURR1 gene expression in patients with Parkinson's disease.

Le WD, Pan T, Xie W, Huang M, Xu P, Zhu W, Zhang X, Deng H, Jankovic J

Ambulatory monitoring of motor fluctuations and freezing of gait: Objective assessment of the efficacy of pharmacological treatments in Parkinson's disease.

Moore ST, MacDougall HG, Ondo WG

Usefulness of [123I]FP-CIT striatal asymmetry index as specific tool to differenziate Parkinson's disease from vascular parkinsonism.

Mostile G, Nicoletti A, Contrafatto D, Lanzafame S, Raciti L, Sorbello V, Bruno E, Dibilio V, Distefano A, Zappia M

Deep brain stimulation of the subthalamic nucleus for peripherally-induced parkinsonism.

Nashatizadeh MM, Jankovic J

A randomized, double-blind, placebo-controlled study of atomoxetine for freezing of gait in Parkinson's disease.

Nashatizadeh MM, Jimenez JE, Davidson AL, Jankovic J

Tolerability and efficacy of switching from swallowed selegiline to zydis selegiline (Zelapar®) in patients with Parkinson's disease.

Ondo WG, Hunter CB, Davidson A, Isaacson SH, Silver DE, Stewart RM, Tetrud JW

Memantine (Namenda®) for non-motor features of Parkinson's disease: A double blind placebo controlled trial.

Ondo WG, Shinawi L, Davidson A

Rapamycin rescues lactacystin-induced dopaminergic neuron injury in vivo.

Pan T, Xie W, Jankovic J, Le WD

Botulinum toxin A in electrical injury-induced cervical myoclonus.

Sitburana O, Ondo WG

Neuropsychological functioning of Parkinson's disease patients two years post subthalamic nucleus deep brain stimulation surgery.

Strutt AM, Jankovic J, York MK

Experience with MRI safety and DBS: Data from the National Parkinson Foundation Centers of Excellence.

Tagliati M, Jankovic J, Koss AM, Pagan F, Okun MS, National Parkinson Foundation DBS Working Group

Volume and nature of patient telephone calls in a large movement disorders center.

Adam OR, Aguilar Tabora LG, Ferrara J, Nashatizadeh M, Jankovic J

Characteristics of archimedean spiral drawing in patients with psychogenic tremor.

Aguilar Tabora LG, Davidson A, Jankovic J, Ondo WG

Morbidity associated with psychogenic movement disorders in children.

Ferrara JM, Jankovic J

Phenomenology of psychogenic movement disorders in children.

Ferrara JM, Jankovic J

New version of the UPDRS (MDS-UPDRS): Factor analysis.

Goetz CG, Tilley BC, Shaftman SR, Fahn S, Martinez-Martin P, Poewe W, et al.

Craving for sweets and other compulsive behaviors in patients with Parkinson's disease.

Jimenez-Shahed J, Calhoun K, Davidson A, Jankovic J

Acamprosate improves impulse control disorders in Parkinson's disease.

Jimenez-Shahed J, Hunter CB, Jankovic J

Treatment of freezing of gait in Parkinson's disease with deep brain stimulation of the pedunculopontine nucleus.

Nashatizadeh M, Jankovic J

A single dose, placebo controlled, cross-over trial comparing the latency to onset of orally disintegrating (OD) levodopa (Parcopa) versus oral (PO) levodopa.

Ondo WG, Shinawi LM, Moore S

Role of deferoxamine and autophagy induction in rotenone-induced apoptosis.

Pan T, Li X, Xie W, Jankovic J, Le WD

Changes in emotional versus physical symptoms of depression following sub-thalamic nucleus deep brain stimulation for Parkinson's disease.

Strutt AM, York MK, Jankovic J

Hemidystonia-hemiatrophy syndrome.

Wijemanne S, Jankovic J

A 25-year-old female with weakness and hearing loss: Charcot-Marie Tooth disease and deafness.

Yaltho TC, Grogan P, Jackson C

Epileptic auras and the outcome of temporal lobectomy.

Gullapalli B, Cavazos JE, Yaltho TC, Mayes BN, Szabo CA

One-year outcome of resective epilepsy surgery.

Yaltho TC, Gullapalli BS, Mayes BN, Cavazos JE, Szabo CA

Rotigotine transdermal patch as a treatment of nocturnal symptoms in patients with idiopathic Parkinson's disease.

Chaudhuri KR, Jankovic J, Trenkwalder C, Boroojerdi B

Clinimetric testing of the new UPDRS (MDS-UPDRS) vs. original version.

Goetz CG, Tilley BC, Shaftman S, Stebbins GT, Fahn S, Martinez-Martin P, et al.

Clinical features of movement disorders in hemochromatosis.

Hall DA, Ringel S, Howard K, Jankovic J

Deep brain stimulation for tardive dyskinesia and akathisia.

Kenney C, Barbano R, Sheffield KJ, Jankovic J

Health related quality of life in essential tremor patients undergoing deep brain stimulation.

Kenney C, Diamond AL, Davidson A, Shinawi LM, Jankovic J

Health related quality of life in Parkinson's disease patients undergoing deep brain stimulation.

Kenney C, Diamond AL, Davidson A, Shinawi LM, Jankovic J

Switch from an oral dopamine agonist to rotigotine transdermal patch in Parkinson's disease.

LeWitt PA, Patton JM, MacMahon DG, Jankovic J

Ambulatory monitoring of freezing of gait in Parkinson's disease.

Moore ST, MacDougall HG, Ondo WG

Safety of concomitant therapy with rasagiline and antidepressants in Parkinson's disease.

Panisset M, Schwid S, Ondo W, Fitzer-Attas C, Chen JJ

Motor and behavioral outcomes after bilateral GPi deep brain stimulation for severe Tourette syndrome.

Shahed J, Poysky J, Kenney C, Simpson R, Jankovic J

Microlesion effects and tremor outcomes in ventrointermediate deep brain stimulation.

Sitburana O, Almaguer M, Ondo W

Weight change in parkinson and alzheimer patients taking atypical antipsychotic drugs.

Sitburana O, Rountree S, Vuong KD, Ondo W

Shoulder pain in Parkinson's disease.

Stamey W, Jankovic J

The other Babinski sign in hemifacial spasm.

Stamey W, Jankovic J

The specificity and sensitivity of "applause sign" in differentiating PSP and other parkinsonian syndromes.

Wu J, Sitburana O, Jankovic J

Brain permeable iron chelators M-30 and AK-28 rescue degenerated nigral dopamine neurons in animal model of PD.

Zhu W, Pan T, Xie W, Jankovic J, Zheng H, Youdim M, Le W

Malignant Tourette syndrome.

Cheung MC, Shahed J, Jankovic J

Three parkin mutations in a family with Parkinson's disease.

Deng H, Le W, Shahed J, Jankovic J

Autopsy-proven Huntington disease with 29 trinucleotide repeats.
[Previously Presented]

Kenney C, Powell S, Jankovic J

Autophagy induction and its neuroprotection on neurotoxin-induced cell injury relevant to Parkinson's disease.

Pan T, Li X, Zhu W, Xie W, Jankovic J, Le W

Motor overflow, contralateral dystonia and mirror movements in focal hand dystonia.

Sitburana O, Wu LJC, Sheffield KJ, Davidson A, Jankovic J

Head injury with amnesia and risk of multiple system atrophy (MSA).

Tanner C, Kukrull W, Shults C, Comyns K, Bhudhikanok G, May S, Goldman S, Meng C, Gilman S, Chade A, Kasten M, Colcher A, Huang N, Jankovic J, Low P, Marshall F, Novak P, Ondo W, Racette B, Reich S, Sandroni P, Stern M, Wooten GF

Novel brain permeable iron chelators prevent lactacystin induced ubiquitn-proteasome inhibition and degeneration of nigrostrialtal dopamine neurons.

Zhu W, Pan T, Xie W, Xu P, Zheng H, Fridkin M, Jankovic J, Youdim MBH, Le W

Proteasome inhibition in substantial nigra induces sustained dopamine cells degeneration.

Zhu W, Pan T, Zhang X, Xie W, Jankovic J, Le W

Comparison of neuroprotective and neurorescue capabilities of rasagiline and selegiline, against lactacystin induced nigrostriatal degeneration.

Zhu W, Pan T, Xie W, Xu P, Jankovic J, Youdim MBH, Le W

Epidemiologic association of Parkinson's disease and melanoma.

Bertoni JM, Arlette JP, Fernandez HH, Frei K, Gordon MF, Hassan MN, Isaacson SH, Lew MF, Molho E, Ondo WG, Phillips TJ, Singer C, Sutton JP, Wolf Jr JE

Comparison of the prevalence and pattern of non-motor symptoms in Parkinson's disease in drug naive and treated patients using the NMSQuest.

Clayton LM, Naidu Y, Odin P, Martinez P, Sethi K, Schapira A, Bonuccelli U, Stocchi F, Rabey M, MacMahon D, MacPhee G, Forbes A, Ondo W, Tsubio Y, Chaudhuri KR

Examination of LRRK2 I2012T, G2019S, and I2020T mutations in patients with essential tremor.

Deng H, Le W, Davidson AL, Xie W, Jankovic J

The effects of subthalamic nucleus deep brain stimulation on parkinsonian tremor.

Diamond A, Shahed J, Jankovic J

Deep brain stimulation of the subthalamic nucleus on Parkinson's disease: Effects on quality of life.

Diamond AL, Vuong KD, Jankovic J

Comparing knowledge and attitudes towards genetic testing in Parkinson's disease in an American and Asian population.

Hunter CB, Tan EK, Lee J, Shinawi LM, Fook-Chong S, Jankovic J

Hyperhidrosis due to thalamic deep brain stimulation in a patient with essential tremor.

Kenney C, Diamond AL, Jankovic J

Clinical features that distinguish psychogenic and essential tremor.

Kenney C, Diamond AL, Mejia N, Hunter CB, Jankovic J

Short-term effects of tetrabenazine on chorea associated with Huntington disease.
[Previously Presented]

Kenney C, Hunter CB, Davidson A, Jankovic J

Autopsy-proven Huntington disease with 29 trinucleotide repeats.

Kenney C, Powell S, Jankovic J

Assessment of locomotor response to levodopa in fluctuating Parkinson's disease.

Moore S, MacDougall H, Gracies J, Ondo W

International validation study of the first comprehensive unified nonmotor symptoms scale (NMSS) for Parkinson's disease (PD).

Naidu Y, Schapira AH, Martinez-Martin P, Sethi K, Odin P, Stocchi F, Ondo W, Olanow CW, Barone P, MacMahon D, MacPhee G, Forbes A, Rabey M, Breen K, Bowron A, Tluk S, Thomas S, Abe K, Williams A, Rye D, Chaudhuri KR

Comparison of weight gain in treatments for Tourette's syndrome: Tetrabenazine versus neuroleptics.

Ondo WG, Jong D, Davidson A

Zonisamide for essential tremor.

Ondo WG, Khan F

Predictors of impulsivity and reward seeking behavior with dopamine agonists.

Ondo WG, Lai D

Sodium oxybate for excessive daytime sleepiness in Parkinson's disease: A polysomnographic study.

Ondo WG, Perkins T, Swick T, Hull, Jr. KL, Jimenez JE, Pardi D

Withdrawal of visual feedback improves micrographia in Parkinson's disease.

Ondo WG, Satija P

Enhancement of autophagy and neuroprotection by rapamycin in lactacystin-induced injury of dopaminergic neurons.

Pan T, Kondo S, Zhu W, Xie W, Jankovic J, Le W

Executive dysfunction and comorbid conditions in Tourette syndrome.

Poysky J, Khan H, Krull K, Jankovic J

Craving sweets in Parkinson's disease.

Shahed J, Davidson A, Jankovic J

GPI deep brain stimulation for Tourette syndrome improves tics and psychiatric co-morbidities.

Shahed J, Poysky J, Kenney C, Simpson Jr RK, Jankovic J

Overflow, contralateral and mirror hand dystonia.

Sitburana O, Jankovic J

Tetrabenazine for hyperglcemic-induced hemichorea-hemiballismus.

Sitburana O, Ondo WG

Hemiparkinsonism-hemiatrophy syndrome.

Wijemanne S, Jankovic J

Different faces of hemifacial spasm: Etiological classification.

Wu LJC, Jankovic J

Runner's dystonia.

Wu LJC, Jankovic J

Relationship of MRI localization and cognition in DBS.

York MK, Wilde E, Simpson Jr RK, Jankovic J

Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation.

Zhao H, Zhu W, Pan T, Xie W, Ondo W, Le W

Examination of LRRK2 I2012T, G2019S, and I2020T mutations in patients with essential tremor.

Deng H, Le W, Guo Y, Hunter CB, Xie W, Huang M, Jankovic J

A Mexican pedigree with Parkinson's disease, essential tremor and bell's palsy associated with parkin but not HS1BP3 gene mutation.

Deng H, Le W, Hunter CB, Xie W, Mejia N, Jankovic J

Genetic analysis of the SLITRK1 gene in caucasian patients with Tourette syndrome.

Deng H, Le W, Xie W, Jankovic J

Deep brain stimulation of the subthalamic nucleus on Parkinson's disease: Effects on quality of life.
[Previously Presented]

Diamond AL, Vuong KD, Jankovic J

Medications associated with the onset of tardive dyskinesia.

Hunter CB, Kenney K, Mejia N, Davidson A, Jankovic J

Short-term effects of tetrabenazine on chorea associated with Huntington disease.

Kenney C, Hunter CB, Davidson A, Jankovic J

Weight change in Parkinson's disease patients taking atypical antipsychotics.
[Previously Presented]

Sitburana O, Ondo WG

An open randomized comparative study of clinical efficacy and safety of Huperzine A and Rivastigmine in treatment of Alzheimer disease.

Wu YC, Zhao YB, Xie YY

Stable suppression of Nurr1 gene using siRNA expression vector in a mouse midbrain dopaminergic cell line.

Wu YC, Zhao YB, Cai YQ, Fei J

International validation of the first unified Non Motor Symptoms Scale for Parkinson's disease. Results from the first pilot NMSS study.

Chaudhuri KR, Martinez-Martin P, Schapira AHV, Sethi K, Ondo W, Stocchi F, Odin P, Brown R, the International PD Non Motor Group (PDNMG)

Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders.

Kenney C, Simpson Jr RK, Hunter CB, Ondo WG, Almaguer M, Davidson A, Jankovic J

Long term safety of deep brain stimulation for the treatment of Parkinson's disease.

Kenney CJ, Vuong K, Hunter C, Almaguer M, Jankovic J

Continuous assessment of gait via stride monitoring: a new approach to management of locomotor dysfunction in Parkinson's disease.

Moore ST, MacDougall HG, Cohen HS, Ondo WG

Nurrl deficiency predisposes to apoptosis induced by lactacystin in SH-SY5Y cells in vitro.

Pan T, Xie W, Deng H, Zhao H, Jankovic J

Bilateral GPI deep brain stimulation for Tourette syndrome.

Shahed J, Poysky J, Kenney C, Simpson Jr RK, Jankovic J

Weight change in Parkinson's disease patients taking atypical antipsychotics.

Sitburana O, Ondo WG

Frontostriatal cognitive functioning 6 months following bilateral subthalamic nucleus deep brain stimulation.

York MK, Jankovic J, Lai EC, Dulay M

Neuropsychological outcome after bilateral deep brain stimulation surgery for advanced Parkinson's disease: Base rates adjusted for practice effects, test unreliability, and natural disease progression.

Dulay MF, York MK, Jankovic J, Simpson Jr RK

Botulinum toxin type B Observational Study (BOS).

Jankovic J, Hunter CB, the BOS Study Group

Genetic analysis of G309D and W4370PA mutations of PINK1 in Parkinson's disease.

Deng H, Le W, Zhang X, Pan T, Jankovic J

New version of the UPDRS: Development methods and working document for field testing.

Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins G, et al.

Early treatment with rasagiline is more beneficial than delayed treatment start in the long-term management of Parkinson's disease.

Hauser R, Lew M, Hurtig H, Ondo W, Wojcieszek J

A variant in the HS1-BP3 gene is associated with familial essential tremor.

Higgins JJ, Lombardi RQ, Pucilowska J, Jankovic J, Tan EK, Rooney JP

Long-term efficacy of rasagiline in Parkinson's disease.

Lew M, Hauser R, Hurtig H, Ondo W, Wojcieszek J

Convergence spasm and other psychogenic eye movement disorders.

Mejia NI, Jankovic J

Tics associated with other disorders.

Mejia NI, Jankovic J

HSP70 inducer VPA inhibits rotenone-induced apoptosis in SH-SY5Y cells.

Pan T, Xie W, Jankovic J, Le W

Characteristics of Parkinson's disease in patients with childhood-onset essential tremor.
[Previously Presented]

Shahed J, Diamond AL, Vuong KD, Jankovic J

Botulinum toxin treatment for oromandibular dystonia and bruxism in patients with Tourette syndrome.

Silay YS, Jankovic J

Gait and balance assessment in parkinsonian disorders.

Azher SN, Vuong KD, Shahed J, Diamond AL, Jankovic J

An international multicentre study validating the first screening questionnaire (NMS-quest) for comprehensive assessment of non motor symptoms of Parkinson's disease.

Chaudhuri KR, Martinez-Martin P, Schapira AHV, Ondo W, Sethi K, Members of The PD NMS Scale Development Group

Small interfering RNA (SiRNA) targeting the PINK1 induces apoptosisin human SH-SY5Y cells.

Deng H, Jankovic J, Pan T, Xie W, Le W

Reduced NURR1 gene expression affects expression of dopaminergic phenotypic markers and Parkinson's disease-related genes.

Deng H, Jankovic J, Xie W, Pan T, Le W

Globus pallidus deep brain stimulation in dystonia.

Diamond AL, Shahed J, Azher SN, Vuong KD, Jankovic J

Relationship among psychiatric, motor and cognitive functioning in non-demented individuals with Parkinson's disease.

Dulay MF, Levin HS, Jankovic J, Lai EC, York MK

Tetrabenazine: Does prior history of depression preclude this drug as a treatment option?

Hunter C, Vuong KD, Mejia N, Jankovic J

Botulinum toxin type B Observational Study (BOS).

Jankovic J, Hunter C, Atassi MZ, Dolimbek BZ, Dolimbek GS, and BOS Research Group

Prevalence of cervical dystonia and spasmodic torticollis in the United States.

Jankovic J, Tsui J, Bergeron C

Medications associated with the onset of tardive dyskinesia.

Mejia N, Vuong KD, Hunter C, Jankovic J

A pilot study of the clinical efficacy and safety of memantine for Huntington's disease.

Mejia NI, Hunter C, Flores K, Ondo WG

Paraspinal muscle asymmetry in Parkinson's disease.

Ondo WG, Haykal HA

The association between restless legs syndrome and essential tremor.

Ondo WG, Lai D

Predictors of battery life for the Activa® Soletra 7426 neurostimulator.

Ondo WG, Meilak C, Vuong KD, Jankovic J

Subthalamic deep brain stimulation in patients with a previous pallidotomy.

Ondo WG, Silay Y, Almaguer M, Jankovic J

Characteristics of Parkinson's disease in patients with childhood-onset essential tremor.

Shahed J, Diamond AL, Vuong KD, Jankovic J

Parkinsonism associated with adalimumab in a patient with rheumatoid arthritis.

Tintner R, Silay YS, Sessoms S, Jankovic J

Botulinum toxin serotype A compared to B in cervical dystonia: Randomized, double-blind, parallel study.

Comella CL, Jankovic J, Leurgans S, Fan W, Chmura T, the Dystonia Study Group

The safety of deep brain stimulation in patients with Parkinson's disease, essential tremor, and other movement disorders.

Silay Y, Jankovic J, Vuong KD, Almageur M, Ondo WG, Tintner R, Simpson Jr RK

Safety and efficacy of tetrabenazine in the treatment of Huntington's disease and other choreas.

Jankovic J, Hunter CB, Vuong KD

Tetrabenazine, a monoamine depleter, effective in the treatment of Tourette syndrome.

Hunter C, Vuong KD, Mejia N, Jankovic J

Tetrabenazine: Effective treatment for tardive dyskinesia.

Jankovic J, Hunter C, Mejia N, Vuong KD

A multicenter, double-blind, placebo-controlled trial of topiramate in essential tremor.

Jankovic J, Ondo WG, Stacy MA, Elble RJ, Pahwa R, Connor GS, Hulihan FJ, Schwarzman L, Wu SC

Nurr1 gene targeting therapy for Parkinson disease.

Le W, Jiang Q, Xie W, Hintermann S, Jankovic J

The pharmacological and biological effects of pramipexole on dopamine neuron associated genes: DAT, VMAT-2, and Nurr1.

Pan T, Xie W, Jankovic J, Le W

Young-onset versus late-onset Parkinson's disease: Clinical features and disease progression.

Silver GA, Vuong KD, Jankovic J

Long-term prognosis of psychogenic movement disorders.

Thomas M, Banuelos P, Vuong KD, Jankovic J

Psychogenic dystonia: Clinical characteristics and long-term progression.

Thomas M, Vuong KD, Jankovic J

A double-blind, randomized, parallel group design comparison of botulinum toxin, type A (Botox) and botulinum toxin, type B (Myobloc) on systemic and ocular autonomic symptoms and physiology in patients with cervical dystonia.

Tintner R, Gross RL, Winzer UF, Smalky KA, Jankovic J

Safety and efficacy of tetrabenazine in childhood hyperkinetic movement disorders.

Vuong KD, Hunter C, Mejia N, Jankovic J

Is depression a predictor of outcome after bilateral subthalamic deep brain stimulation in patients with Parkinson's disease?

York MK, Silay YS, Chaytor N, Simpson Jr RK, Jankovic J

Camptocormia: Pathogenesis, classification and response to therapy.

Azher S, Jankovic J

Genome-wide model-based and model-free linkage analyses co-localize a novel genetic locus on chromosome 9p for familial restless legs syndrome.

Chen S, Ondo WG, Rao S, Li L, Wang Q

Interim results of an observational study of neutralizing antibody formation with the current preparation of botulinum toxin type A treatment for cervical dystonia.

Comella CL, Jankovic J, Daggett S, Mordaunt J, Brin MF

Haplotype analysis at the ETM2 locus in American and Singaporean populations with familial essential tremor.

Higgins JJ, Lombardi RQ, Tan EK, Jankovic J, Pucilowska J, Rooney JP

Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders.

Hunter CB, Vuong KD, Jankovic J

Essential tremor in children.

Jankovic J, Madisetty J, Vuong KD

Psychogenic tremor: Long-term outcome.

Jankovic J, Vuong KD, Thomas M

Effects of ropinirole on progression of parkinsonism in Nurr1-deficient mice and its underlying mechanisms.

Jiang C, Pan T, Jankovic J, Le W

Dopaminergic properties and anti-parkinsonian effects of IPX750 in rodent models of Parkinson's disease.

Jiang C, Wan X, Jankovic J, Christian S, Sundsmo J, Le W

The north American survey of placement and adjustment strategies for deep brain stimulation.

Ondo WG, Bronte-Stewart H for the DBS Study Group

The pharmacological and biological effects of pramipexole on dopamine transporter.

Pan T, Jankovic J, Le W

Decreased Nurr1 mRNA in peripheral blood lymphocytes in Parkinson's disease.

Pan T, Xie W, Jankovic J, Le W

The efficacy and safety of fluphenazine in patients with Tourette syndrome.

Silay YS, Vuong KD, Jankovic J

A double-blind, randomized, parallel group design comparison of botulinum toxin, type A (Botox®) and botulinum toxin, type B (Myobloc™) on autonomic symptoms and physiology in patients with cervical dystonia.

Tintner R, Winzer UF, Smalky KA, Jankovic J

Tetrabenazine in the treatment of chorea.

Jankovic J, Hunter CB, Vuong KD

Information processing speed influences the component processes of verbal working memory in Parkinson's disease patients.

York MK, Levin HS, Soety EM, Lai EC, Jankovic J, Grossman RG

Haplotype analysis of unrelated individuals with familial essential tremor.

Higgins JJ, Jankovic J, Lombardi RQ, Pucilowska J, Tan EK, Ashizawa T, Ruszczyk MU

Comparison of postoperative improvement of staged bilateral subthalamic stimulation in patients with advanced Parkinson's disease.

Kuniyoshi S, Tintner R, Ondo W, Simpson R, Jankovic J

Apolipoprotein E controls risk and age at onset of Parkinson disease.

Li Y-J, Martin ER, Scott WK, Haines JL, Nance MA, Hubble JP, Hiner BC, Jankovic J, Goetz CG, Small GW, Gibson RA, Middleton LT, Vance JM

Glutathione S-Transferase, Omega-1 (GSTO1) modifies age at onset of Alzheimer disease and Parkinson disease.

Li Y-J, Oliveria AS, Hauser MA, Hauser ER, Scott WK, Stenger JE, Hubble JP, Koller WC, Hiner BC, Jankovic J, Allen Jr FH, Roses AD, Saunders AM, Schmechel DA, Small GW, Gullans SR, Gilbert JR, Vance JM, Pericak-Vance MA

A double blind placebo controlled parallel trial of botulinum toxin B (Myobloc™) for the treatment of sialorrhea in parkinson disease.

Ondo WG, Hunter CB, Moore W

Long term treatment of restless legs syndrome with dopamine agonists.

Ondo WG, Romanyshyn J, Vuong KD

The epidemiology of myoclonus in the medical and surgical intensive care unit (ICU).

Tintner R, Kuniyoshi SM, Gonzalez A, Jankovic J

Specific mitochondrial haplogroups affect risk for late-onset Parkinson disease.

Van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Haines JL, McLaurin AC, Nance MA, Hubble JP, Koller WC, Padwa R, Stern MB, Hiner BC, Jankovic J, Goetz CG, Small GW, Mastaglia F, Gibson RA, Middleton LT, Pericak-Vance MA, Vance JM

Treatment of hypophonia with collagen vocal fold augmentation in patients with parkinsonism.

Hill AN, Jankovic J, Vuong KD, Donovan D

Age-related tolerability of tetrabenazine.

Hunter CB, Wang A, Vuong KD, Jankovic J

Tetrabenazine in the treatment of Tourette syndrome.

Hunter CB, Wang A, Vuong KD, Jankovic J

Premonitory sensations in tics.

Kwak CH, Jankovic J

Reduced Nurr1 expression increases the susceptibility to dopaminergic toxins via nitric oxide.

Le W, Imam SZ, Xie W, Ali S, Jankovic J

Computerized posturography balance assessment of patients with bilateral vim deep brain stimulation.

Ondo WG, Cohen H, Almaguer M, Jankovic J

Evaluating factors that can influence spirography ratings in patients with essential tremor.

Ondo WG, Wang A, Thomas M, Vuong KD

Upregulation of Nurr1 gene expression by dopamine receptor agonist pramipexole in human neuroblastoma SHSY-5Y cells.

Pan TH, Xu PY, Xie WJ, Hunter C, Jankovic J, Le WD

Reliability of limits of stability measures in Parkinson's disease.

Protas EJ, Thomas M, Cunha IT, Caroline KS, Wankadia S, Jankovic J

Minocycline in Huntington's disease: A pilot study.

Thomas M, Ashizawa T, Jankovic J

Gait and Balance Scale (GABS): Validation and utilization.

Thomas M, Jankovic J, Suteerawattanon M, Wankadia S, Caroline K, Protas E

Experience with bilateral subthalamic nucleus (STN) stimulation for Parkinson's disease (PD).

Tintner R, Almaguer M, Sanghera M, Simpson R, Ondo WG, Jankovic J

Predictors of response to bilateral subthalamic nucleus stimulation for Parkinson's disease.

Tintner R, Almaguer M, Vuong KD, Ondo WG, Jankovic J, Sanghera M

Pleuropulmonary fibrosis after 11 years of pergolide treatment.

Tintner R, Manian P, Gauthier P, Jankovic J

The efficacy and safety of Dysport (botulinum type A toxin) in cervical dystonia: Results of the first US study.

Truong DD, Duane DD, Jankovic J, Singer C, Comella CL, the US Dysport Dystonia Study Group

Dystonia in Friedreich's ataxia.

Hou JG, Jankovic J

Botulinum toxin A (Botox) for chronic daily headache: A randomized placebo-controlled, parallel design study.

Ondo WG, Vuong KD, Derman HS

Comparison of immunogenicity of old versus current Botox in cervical dystonia.

Jankovic J, Ahsan J, Vuong KD

The prevalence of restless legs syndrome in patients with Parkinson's disease.

Atassi F, Vuong KD, Jankovic J, Ondo WG

Exploring the relationship between Parkinson's disease and restless legs syndrome.

Ondo WG, Vuong KD, Jankovic J

Olanzapine treatment for dopaminergic induced hallucinations.

Ondo WG, Hunter C, Vuong KD, Jankovic J

Daytime sleepiness in patients with Parkinson's disease.

Ondo WG, Vuong KD, Atassi F, Khan H, Kwak C, Jankovic J

Unilateral thalamic deep brain stimulation for essential tremor and Parkinson's disease: Effects of stimulation on the non-target limb and rebound augmentation.

Vuong KD, Ondo WnG, Almaguer M, Simpson RK, Jankovic J

Neuropsychological distinctions between cortico-basal ganglionic degeneration (CBGD) and Alzheimer's disease with extrapyramidal signs.

Massman PJ, Kreiter KT, Jankovic J, Doody RS

Neuropsychological differentiation of corticobasal degeneration from Alzheimer's disease.

Massman PJ, Kreiter KT, Jankovic J, Doody RS

The alien hand and related signs.

Doody RS, Jankovic J